Medline Inc. (MDLN) Operating Margin
- Operating margin · 12 months: Value 6.07%; Formula and calculation Operating income / revenue. Period ending 2026-06-27..
Operating margin
Overview →Financial period ending 2026-06-27; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Operating margin · 12 months | 6.07% | Operating income / revenue. Period ending 2026-06-27. $1.82B ÷ $29.94B × 100 ≈ 6.07% |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Operating income | 1.82B USD | Operating Income (Loss) |
| Revenue | 29.94B USD | |
| Cost of products and services | 22.09B USD | Cost of Goods and Services Sold |
| Research and development | (m) | Research and Development Expense |
| Selling, general and administration | 4.90B USD | Selling, General and Administrative Expense |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Operating income (USD) | Revenue (USD) | Cost of products and services (USD) | Research and development (USD) | Selling, general and administration (USD) | Operating margin |
|---|---|---|---|---|---|---|
| 2026-06-27 | $1.82B | $29.94B | $22.09B | (m) | $4.90B | 6.07% |
| 2026-03-28 | $2.06B | $29.14B | $21.61B | (m) | $4.68B | 7.08% |
| 2025-12-31 | $2.21B | $28.43B | $20.91B | $80.00M | $4.52B | 7.78% |
| 2025-06-28 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-03-29 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-12-31 | $2.15B | $25.51B | $18.53B | $67.00M | $4.11B | 8.41% |
| 2023-12-31 | $1.25B | $23.23B | $17.35B | $60.00M | $3.87B | 5.38% |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.